Assessment of determinant factors of willingness to pay for dengue vaccine: multicenter and cross-sectional study in Southeast Sulawesi, Indonesia [0.03%]
登革热疫苗支付意愿决定因素的评估：印度尼西亚东南苏拉威西多中心横断面研究
Muhamad Ramadhan Salam,Restu Nur Hasanah Haris,Rachma Malina et al.
Muhamad Ramadhan Salam et al.
Purpose: Enhancing vaccine coverage among children is crucial to preventing the long-term consequences of dengue fever (DF) infections. This study aims to identify sociodemographic factors influencing parents' willingness...
Post-authorisation effectiveness and safety study: a multicenter observational study of the effectiveness and safety of the inactivated SARS-CoV-2 vaccine [0.03%]
关于新型冠状病毒灭活疫苗序贯加强免疫的有效性和安全性多中心观察性研究
Nawal Alkaabi,Salah El Din Hussein Mohamed,Faduma Mohamed Ismail et al.
Nawal Alkaabi et al.
Purpose: The coronavirus disease 2019 (COVID-19) pandemic led to the rapid development of vaccines to control the spread of infection. The inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Sinopharm...
Acute tubulointerstitial nephritis after the second dose of the Pfizer COVID-19 vaccine [0.03%]
第二次接种辉瑞COVID-19疫苗后急性肾小管间质炎
Rebecca Lendway,Christie Beneri,Katarina Supe-Markovina
Rebecca Lendway
Coronavirus disease 2019 (COVID-19) vaccine has been extended to children 6 months and older and boosters to those 12 years and older, and vaccine safety continues to be monitored. A 12-year-old female presented with non-oliguric acute kidn...
Cytokine responses to respiratory syncytial virus infection in well-differentiated infant nasal epithelial cell cultures [0.03%]
呼吸道合胞病毒对鼻上皮细胞培养的细胞因子反应
Ki Wook Yun,Phylip Chen,Susan D Reynolds et al.
Ki Wook Yun et al.
Purpose: Differentiated airway epithelial cell cultures closely mimic the in vivo airways. We compared the structure and cytokine response of well-differentiated human nasal epithelial (HNE) cells obtained from healthy in...
Cholera toxin B subunit fusion enhances the immunogenicity of the H5 stem domain against the H5N2 avian influenza virus [0.03%]
霍乱类毒素B亚基融合增强H5流感病毒茎部结构抗原性对抗H5N2禽流感病毒感染
Chan Lee,Seongjae Kim,Jinseon You et al.
Chan Lee et al.
Purpose: The development of a universal avian influenza vaccine remains a critical issue for both the global public health and poultry industries. The hemagglutinin (H) stem/stalk region of highly pathogenic avian influen...
A narrative review of monkey B virus (Macacine alphaherpesvirus 1): infection, transmission, and post-exposure prophylaxis [0.03%]
猴B病毒（猕猴α- herpes病毒1型）的叙事性综述：感染、传播和暴露后预防措施
Hyoungjoon Moon,Kwang-Soo Lyoo
Hyoungjoon Moon
Herpes B virus (BV) is enzootic to macaques and represents a significant zoonotic threat to humans. In macaques, the viral infection is typically latent and asymptomatic, however, BV can become a deadly neurotropic infection in humans, comm...
Alopecia universalis following human papillomavirus vaccine administration: a case report [0.03%]
人乳头瘤病毒疫苗接种后的普秃1例报告
Yinhua Wu,Xiaoyan Liu,Jianjun Qiao et al.
Yinhua Wu et al.
The 9-valent human papillomavirus vaccine (9vHPV) protects against 9 HPV genotypes linked to cervical cancer and genital warts. While rare, HPV vaccines may trigger autoimmune reactions. Alopecia areata (AA) is a chronic autoimmune disease ...
Mourad Elghali,Mariem Mhiri,Imene Chaabane et al.
Mourad Elghali et al.
Purpose: To present, to the best of our knowledge, the largest African case series of autoimmune manifestations (AIM) after coronavirus disease 2019 (COVID-19) vaccination. ...
Safety and efficacy of maternal RSV vaccination: a systematic review and meta-analysis [0.03%]
RSV疫苗的母体免疫：一项系统性回顾和meta分析
Ahmed Farag,Mohamed Karam Allah Elkholy,Amany Mahmoud Genidy et al.
Ahmed Farag et al.
Respiratory syncytial virus (RSV) maternal vaccination has emerged as a preventive strategy to confer passive immunity to newborn during their early vulnerable months of life. In this review, we aim to assess the efficacy and safety of mate...
Advancements and challenges in next-generation mRNA vaccine manufacturing systems [0.03%]
下一代mRNA疫苗生产系统的进展与挑战
Sang Hwan Seo,Man Ki Song
Sang Hwan Seo
The coronavirus disease 2019 pandemic has accelerated the global adoption and development of messenger RNA (mRNA) vaccine technology. While traditional manufacturing approaches rely on centralized and batch-based processes that are limited ...